⌘K

Login Start Free

Home/Filings/4/0001185185-19-001751

4//SEC Filing

TOMAS MIKE 4

Accession 0001185185-19-001751

CIK 0001388319other

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:17 PM ET

Size

8.2 KB

Accession

0001185185-19-001751

Insider Transaction Report

Form 4

Period: 2019-09-01

U.S. Stem Cell, Inc.USRM

DirectorCEO & President

Transactions

Award
Stock Option (right to buy)
2019-09-01+20,000,000→ 80,041,284 total
Exercise: $0.01Exp: 2029-09-01→ Common Stock (20,000,000 underlying)
Award
Stock Option (right to buy)
2019-11-18+1,500,000→ 81,541,284 total
Exercise: $0.00From: 2019-11-18Exp: 2029-11-18→ Common Stock (1,500,000 underlying)

Holdings

Common Stock
9,793

Footnotes (1)

[F1]5,000,000 vest on 09/01/2020, 5,000,000 vest on 09/01/2021, 5,000,000 vest on 09/01/2022, 5,000,000 vest on 09/01/2023.

Documents

1 file

4
ownership.xmlPrimary

Issuer

U.S. Stem Cell, Inc.

CIK 0001388319

Entity typeother

Related Parties

1

filerCIK 0001388662

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 4:17 PM ET
Size: 8.2 KB

View on SEC.gov